Effect of the COVID-19 pandemic on acute stroke reperfusion therapy: data from the Lyon Stroke Center Network
Cécile Plumereau(Hospices Civils de Lyon), Laura Mechtouff(Hospices Civils de Lyon), Marion Douplat(Hospices Civils de Lyon), Laurent Derex(Centre National de la Recherche Scientifique), Elodie Ong(Lyon 1 Université), David Schiavo(Hospices Civils de Lyon), Karim Tazarourte(Université Claude Bernard Lyon 1), Omer Eker(Inserm), Célia Tuttle(Hospices Civils de Lyon), Matteo Cappucci(Olea Medical (France)), Camille Amaz(Université Claude Bernard Lyon 1), Tae‐Hee Cho(Lyon 1 Université), Yves Berthezène(Université Claude Bernard Lyon 1), Lucie Rascle(Anna Needs Neuroblastoma Answers), Thomas Bony(Hospices Civils de Lyon), Norbert Nighoghossian(Hospices Civils de Lyon), Roberto Riva(Hospices Civils de Lyon), Michel Ovize(Université Claude Bernard Lyon 1), Julia Fontaine(Communauté urbaine de Lyon), Marielle Buisson(Inserm), Axel Benhamed(Centre hospitalier universitaire de Québec)
Cited by 3
Related Papers
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
How Does Amniotic Membrane Work?
|The Ocular Surface|2004|312
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial
|The Lancet|2022|292
Remote Ischemic Perconditioning as an Adjunct Therapy to Thrombolysis in Patients With Acute Ischemic Stroke
|Stroke|2013|282
Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size
|New England Journal of Medicine|2024|276